For the year ending 2025-12-31, RCEL made $71,610K in revenue. -$48,587K in net income. Net profit margin of -67.85%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Total revenues | 71,610 | |||
| Cost of sales | 12,794 | |||
| Gross profit | 58,816 | |||
| Sales and marketing | 53,138 | |||
| General and administrative | 27,373 | |||
| Research and development | 20,839 | |||
| Total operating expenses | 101,350 | |||
| Operating loss | -42,534 | |||
| Interest expense | 5,004 | |||
| Other (expense) income, net | -1,038 | |||
| Loss before income taxes | -48,576 | |||
| Income tax expense | 11 | |||
| Net loss | -48,587 | |||
| Earnings per share, basic | -1.74 | |||
| Earnings per share, diluted | -1.74 | |||
| Weighted average number of shares outstanding, basic | 27,860,784 | |||
| Weighted average number of shares outstanding, diluted | 27,860,784 | |||
AVITA Medical, Inc. (RCEL)
AVITA Medical, Inc. (RCEL)